Thymalfasin

• Description :

  Thymalfasin is an immunomodulating agent able to enhance the Thl immune response.

• CAS Number :

  [62304-98-7]

• Product Name Alternative :

  Thymosin α1

• UNSPSC :

  12352209

• Target :

  Influenza Virus

• Type :

  Peptides

• Related Pathways :

  Anti-infection

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/Thymalfasin.html

• Purity :

  99.25

• Solubility :

  H2O : 0.3 mg/mL (ultrasonic; warming)

• Smiles :

  [C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(C)=O)CO)=O)CC(O)=O)=O)C)=O)C)=O)C(C)C)=O)CC(O)=O)=O)[C@@H](C)O)=O)CO)=O)CO)=O)CCC(O)=O)=O)[C@H](CC)C)=O)[C@@H](C)O)=O)[C@@H](C)O)=O)CCCCN)=O)CC(O)=O)=O)CC(C)C)=O)CCCCN)=O)CCC(O)=O)=O)CCCCN)=O)(C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(N)=O)C(O)=O)=O)CCC(O)=O)=O)C)=O)CCC(O)=O)=O)CCC(O)=O)=O)C(C)C)=O)[C@H](C)C)=O)CCC(O)=O)=O)CCCCN

• Molecular Formula :

  C129H215N33O55

• Molecular Weight :

  3108.28

• References & Citations :

  [1]Lao X et al. A modified thymosin alpha 1 inhibits the growth of breast cancer both in vitro and in vivo: suppressment of cell proliferation, inducible cell apoptosis and enhancement of targeted anticancer effects. Apoptosis. 2015 Oct;20 (10) :1307-20.|[2]Sjogren MH et al. Thymalfasin: an immune system enhancer for the treatment of liver disease. J Gastroenterol Hepatol. 2004 Dec;19 (12) :S69-72.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Scientific Category :

  Peptides

• Clinical Information :

  Launched